Spectrum evaluation-assisted eicosanoid metabolomics for global eicosanoid profiling in human vascular endothelial cells
- PMID: 28755503
- DOI: 10.1111/1440-1681.12825
Spectrum evaluation-assisted eicosanoid metabolomics for global eicosanoid profiling in human vascular endothelial cells
Abstract
Eicosanoids are hundreds of metabolites derived from poly-unsaturated fatty acids (PUFAs), which regulate biological processes from multiple angles via a complex metabolic network. Targeted eicosanoid metabolomics is used to study the eicosanoid profile in biological samples but only for eicosanoids with available standards. To expand the coverage of eicosanoids detected, we identified the eicosanoids without available standards by estimation of the retention time and comparison of the MS/MS spectra with the reference ones which was collected in a database from literature. Scheduled multiple reaction monitoring- information dependent acquisition- enhanced product ion (sMRM-IDA-EPI) scan mode was applied in this method, which was called Spectrum Evaluation-assisted Eicosanoid Metabolomics (SEEM). By using this method, 243 eicosanoids (167 without standards) could be relatively quantified with precision over 90 percent. We applied the method to analyze the global profile of eicosanoids secreted by human umbilical vascular endothelial cells at the basal level and with n-3 PUFA treatment. 26 putative eicosanoids showed altered levels, despite no available standards. In general, n-3 PUFA treatment increased most of their own metabolites and decreased the epoxy-, hydroxyl- and keto- linoleic acid metabolites. The application of the SEEM method proved its potency of identification and quantification of eicosanoids without standards.
Keywords: eicosanoid; endothelial cells; metabolomics; n-3 poly-unsaturated fatty acids.
© 2017 John Wiley & Sons Australia, Ltd.
Similar articles
-
Systematic metabolomic analysis of eicosanoids after omega-3 polyunsaturated fatty acid supplementation by a highly specific liquid chromatography-tandem mass spectrometry-based method.J Proteome Res. 2015 Apr 3;14(4):1843-53. doi: 10.1021/pr501200u. Epub 2015 Mar 17. J Proteome Res. 2015. PMID: 25736083
-
Metabolomics revealed decreased level of omega-3 PUFA-derived protective eicosanoids in pregnant women with pre-eclampsia.Clin Exp Pharmacol Physiol. 2019 Aug;46(8):705-710. doi: 10.1111/1440-1681.13095. Epub 2019 May 5. Clin Exp Pharmacol Physiol. 2019. PMID: 30983029
-
Quantitative profiling of eicosanoids derived from n-6 and n-3 polyunsaturated fatty acids by twin derivatization strategy combined with LC-MS/MS in patients with type 2 diabetes mellitus.Anal Chim Acta. 2020 Jul 11;1120:24-35. doi: 10.1016/j.aca.2020.04.064. Epub 2020 Apr 28. Anal Chim Acta. 2020. PMID: 32475388
-
Omega-3 PUFA attenuate mice myocardial infarction injury by emerging a protective eicosanoid pattern.Prostaglandins Other Lipid Mediat. 2018 Nov;139:1-9. doi: 10.1016/j.prostaglandins.2018.09.002. Epub 2018 Sep 14. Prostaglandins Other Lipid Mediat. 2018. PMID: 30223037 Review.
-
[Research progress of eicosanoid metabolomics in cardiovascular diseases].Sheng Li Xue Bao. 2021 Aug 25;73(4):606-616. Sheng Li Xue Bao. 2021. PMID: 34405217 Review. Chinese.
Cited by
-
Senescence-associated 13-HODE production promotes age-related liver steatosis by directly inhibiting catalase activity.Nat Commun. 2023 Dec 9;14(1):8151. doi: 10.1038/s41467-023-44026-z. Nat Commun. 2023. PMID: 38071367 Free PMC article.
-
The Diagnostic Significance of Circulating Eicosanoid in Patients with Hypertrophic Cardiomyopathy.J Cardiovasc Transl Res. 2025 Jul 21. doi: 10.1007/s12265-025-10652-9. Online ahead of print. J Cardiovasc Transl Res. 2025. PMID: 40691389
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources